Any solvency deficit risks a global arms race.
Almosara 10 [Joel O.; 6/?/2010 ; The senior consultant to the Pacific Air Forces Surgeon General and commanders on occupational and environmental health programs and Deputy Director of the USAF Counterproliferation Center ; “BIOTECHNOLOGY: GENETICALLY ENGINEERED PATHOGENS,” https://media.defense.gov/2019/Apr/11/2002115517/-1/-1/0/53ALMOSARAMONO.PDF]
The developmental trends in biological sciences indicate there is a plethora of possibilities concerning the study of microorganisms and its applicability in creating the next biological warfare agent. Both historical and recent events show the potentially devastating effect of using biological warfare agents and the terror they cause among the populace. Even more alarming is that technological advancements in the field of biological sciences will transform biological warfare agents into a new classification of genetically engineered pathogens eliciting catastrophic consequences. 2 Just as the twentieth century was the “century of chemistry and physics,” the twenty-first century will emerge as the “century of biology.” Nations, groups, and individuals that have the resources, capabilities, and knowledge to develop this technology in the year 2035 will have the global arms race advantage.